APhA migraine special report
This article was originally published in The Tan Sheet
Continuing education program for pharmacists on "Self-Treatment of Migraine and Other Types of Headache" is being distributed to members of the American Pharmaceutical Association. The CME materials instruct pharmacists on how to accurately assess migraine headaches and when to recommend OTC therapies. The program was sponsored by Bristol-Myers Squibb, the marketer of Excedrin Migraine, which was approved for OTC treatment of migraine Jan. 14 ("The Tan Sheet" Jan. 19, p. 14)...
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC